ISRG
VENTE TOTALE: 472 titres (~179 903,20 $ US)
- Insiders
- Ladd Amy L
- Total bought
- —
- Total sold
- $179,903
- Last activity
- 2026-08-11
- Last synced
-
2026-08-21 23:36:53
Insider holdings as a share of total assets aren't available for this company.
Price (1 year)
Live chart from TradingView - pulls its own market data, independent of this site's database. Symbol resolution is best-effort (defaults to NASDAQ) since we don't store the exchange prefix.
Market snapshot
Signal
Neutral signal Scored 2026-08-13
The 0-100 score behind this signal and the full written analysis are part of Plus. See plans.
Financial ratios
| Metric | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|---|
| Gross Profit Margin | 66.0% | 67.5% | 66.4% | 67.4% | 69.3% | |
| Ebit Margin | 32.9% | 32.0% | 27.5% | 25.8% | 33.1% | |
| Ebitda Margin | 39.6% | 37.5% | 33.1% | 31.7% | 38.7% | |
| Operating Profit Margin | 29.3% | 28.1% | 24.8% | 25.3% | 31.9% | |
| Pretax Profit Margin | 32.9% | 32.0% | 27.5% | 25.8% | 33.1% | |
| Continuous Operations Profit Margin | 28.6% | 28.0% | 25.5% | 21.6% | 30.3% | |
| Net Profit Margin | 28.4% | 27.8% | 25.2% | 21.3% | 29.9% | |
| Bottom Line Profit Margin | 28.4% | 27.8% | 25.2% | 21.3% | 29.9% | |
| Current Ratio | 4.875 | 4.074 | 4.756 | 4.397 | 5.083 | |
| Quick Ratio | 3.957 | 3.222 | 4.020 | 3.769 | 4.573 | |
| Solvency Ratio | 1.314 | 1.206 | 1.076 | 0.907 | 1.261 | |
| Cash Ratio | 1.679 | 1.162 | 1.658 | 1.112 | 1.123 | |
| Price To Earnings Ratio | 70.795 | 79.810 | 65.891 | 71.331 | 75.010 | |
| Price To Earnings Growth Ratio | 3.171 | 2.878 | 1.751 | -3.193 | 1.280 | |
| Forward Price To Earnings Growth Ratio | 3.171 | 2.878 | 1.751 | -3.193 | 1.280 | |
| Price To Earnings Diluted Ratio | 71.964 | 81.302 | 67.070 | 72.699 | 77.103 | |
| Price To Earnings Diluted Growth Ratio | 3.186 | 2.942 | 1.774 | -3.354 | 1.318 | |
| Price To Book Ratio | 11.341 | 11.282 | 8.903 | 8.548 | 10.705 | |
| Price To Sales Ratio | 20.083 | 22.198 | 16.631 | 15.169 | 22.407 | |
| Price To Free Cash Flow Ratio | 81.155 | 142.200 | 158.059 | 98.482 | 73.706 | |
| Price To Operating Cash Flow Ratio | 66.700 | 76.770 | 65.322 | 63.312 | 61.236 | |
| Debt To Assets Ratio | 0.015 | 0.008 | 0.000 | 0.000 | 0.006 | |
| Debt To Equity Ratio | 0.017 | 0.009 | 0.000 | 0.000 | 0.007 | |
| Debt To Capital Ratio | 0.017 | 0.009 | 0.000 | 0.000 | 0.007 | |
| Long Term Debt To Capital Ratio | 0.007 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Financial Leverage Ratio | 1.157 | 1.146 | 1.160 | 1.175 | 1.134 | |
| Working Capital Turnover Ratio | 1.532 | 1.441 | 1.288 | 1.306 | 1.103 | |
| Operating Cash Flow Ratio | 1.511 | 1.384 | 1.094 | 1.048 | 1.817 | |
| Operating Cash Flow Sales Ratio | 0.301 | 0.289 | 0.255 | 0.240 | 0.366 | |
| Free Cash Flow Operating Cash Flow Ratio | 0.822 | 0.540 | 0.413 | 0.643 | 0.831 | |
| Debt Service Coverage Ratio | 91.121 | 83.567 | 0.000 | 0.000 | 0.000 | |
| Interest Coverage Ratio | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Operating Cash Flow Coverage Ratio | 77.705 | 72.090 | 0.000 | 0.000 | 0.000 | |
| Operating Cash Flow Coverage Ratio | 10.008 | 16.541 | 0.000 | 0.000 | 24.016 | |
| Capital Expenditure Coverage Ratio | 5.614 | 2.173 | 1.704 | 2.800 | 5.911 | |
| Dividend Paid And Capex Coverage Ratio | 5.614 | 2.173 | 1.704 | 2.800 | 5.911 | |
| Dividend Payout Ratio | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Enterprise Value Multiple | 49.911 | 58.524 | 49.016 | 47.046 | 57.420 |
Sparkline shows each ratio oldest → newest (left → right).
How the latest year compares
For each ratio: its most recent value, the change versus one year earlier, and versus its 5-year average. ▲ higher ▼ lower
| Metric | Current | vs 1Y ago | vs 5Y avg |
|---|---|---|---|
| Gross Profit Margin | 66.0% | ▼-1.5% | ▼-1.3% |
| Ebit Margin | 32.9% | ▲0.9% | ▲2.6% |
| Ebitda Margin | 39.6% | ▲2.1% | ▲3.5% |
| Operating Profit Margin | 29.3% | ▲1.1% | ▲1.4% |
| Pretax Profit Margin | 32.9% | ▲0.9% | ▲2.6% |
| Continuous Operations Profit Margin | 28.6% | ▲0.6% | ▲1.8% |
| Net Profit Margin | 28.4% | ▲0.6% | ▲1.9% |
| Bottom Line Profit Margin | 28.4% | ▲0.6% | ▲1.9% |
| Current Ratio | 4.875 | ▲0.800 | ▲0.238 |
| Quick Ratio | 3.958 | ▲0.735 | ▲0.049 |
| Solvency Ratio | 1.314 | ▲0.108 | ▲0.161 |
| Cash Ratio | 1.679 | ▲0.517 | ▲0.332 |
| Price To Earnings Ratio | 70.795 | ▼-9.015 | ▼-1.772 |
| Price To Earnings Growth Ratio | 3.171 | ▲0.294 | ▲1.994 |
| Forward Price To Earnings Growth Ratio | 3.171 | ▲0.294 | ▲1.994 |
| Price To Earnings Diluted Ratio | 71.964 | ▼-9.338 | ▼-2.063 |
| Price To Earnings Diluted Growth Ratio | 3.186 | ▲0.244 | ▲2.013 |
| Price To Book Ratio | 11.341 | ▲0.059 | ▲1.185 |
| Price To Sales Ratio | 20.083 | ▼-2.115 | ▲0.786 |
| Price To Free Cash Flow Ratio | 81.156 | ▼-61.044 | ▼-29.565 |
| Price To Operating Cash Flow Ratio | 66.700 | ▼-10.070 | ▲0.032 |
| Debt To Assets Ratio | 0.015 | ▲0.007 | ▲0.009 |
| Debt To Equity Ratio | 0.017 | ▲0.008 | ▲0.010 |
| Debt To Capital Ratio | 0.017 | ▲0.008 | ▲0.010 |
| Long Term Debt To Capital Ratio | 0.007 | ▲0.007 | ▲0.006 |
| Financial Leverage Ratio | 1.157 | ▲0.011 | ▲0.003 |
| Working Capital Turnover Ratio | 1.532 | ▲0.091 | ▲0.198 |
| Operating Cash Flow Ratio | 1.511 | ▲0.127 | ▲0.140 |
| Operating Cash Flow Sales Ratio | 0.301 | ▲0.012 | ▲0.011 |
| Free Cash Flow Operating Cash Flow Ratio | 0.822 | ▲0.282 | ▲0.172 |
| Debt Service Coverage Ratio | 91.121 | ▲7.553 | ▲56.183 |
| Interest Coverage Ratio | 0.000 | 0.000 | 0.000 |
| Short Term Operating Cash Flow Coverage Ratio | 77.705 | ▲5.616 | ▲47.746 |
| Operating Cash Flow Coverage Ratio | 10.008 | ▼-6.533 | ▼-0.105 |
| Capital Expenditure Coverage Ratio | 5.614 | ▲3.441 | ▲1.974 |
| Dividend Paid And Capex Coverage Ratio | 5.614 | ▲3.441 | ▲1.974 |
| Dividend Payout Ratio | 0.000 | 0.000 | 0.000 |
| Enterprise Value Multiple | 49.911 | ▼-8.613 | ▼-2.473 |
Key metrics
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Market cap | $202.13B | $185.40B | $118.48B | $94.38B | $127.95B | |
| Enterprise value | $199.07B | $183.52B | $115.73B | $92.80B | $126.74B | |
| EV / Sales | 19.78x | 21.97x | 16.25x | 14.91x | 22.20x | |
| EV / Op. cash flow | 65.69x | 75.99x | 63.81x | 62.25x | 60.66x | |
| EV / Free cash flow | 79.92x | 140.76x | 154.39x | 96.83x | 73.01x | |
| EV / EBITDA | 49.91x | 58.52x | 49.02x | 47.05x | 57.42x | |
| Net debt / EBITDA | -0.77x | -0.60x | -1.17x | -0.80x | -0.55x | |
| Current ratio | 4.88x | 4.07x | 4.76x | 4.40x | 5.08x | |
| Income quality | 1.05x | 1.03x | 1.00x | 1.11x | 1.21x | |
| Graham number | $95 | $83 | $66 | $51 | $60 | |
| Graham net-net | $15 | $10 | $13 | $10 | $10 | |
| Tax burden | 86.2% | 86.9% | 91.8% | 82.3% | 90.2% | |
| Interest burden | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| Working capital | $7.77B | $5.37B | $6.23B | $4.83B | $4.70B | |
| Invested capital | $13.50B | $10.52B | $10.15B | $7.60B | $6.99B | |
| Return on assets | 13.8% | 12.3% | 11.6% | 10.2% | 12.6% | |
| Operating ROA | 14.9% | 13.7% | 12.4% | 11.9% | 14.7% | |
| Return on tangible assets | 14.1% | 12.6% | 11.9% | 10.5% | 13.0% | |
| Return on equity | 16.0% | 14.1% | 13.5% | 12.0% | 14.3% | |
| Return on invested capital | 13.7% | 12.0% | 11.9% | 11.4% | 13.4% | |
| Return on capital employed | 15.8% | 13.7% | 12.8% | 13.7% | 14.7% | |
| Earnings yield | 1.4% | 1.3% | 1.5% | 1.4% | 1.3% | |
| Free cash flow yield | 1.2% | 0.7% | 0.6% | 1.0% | 1.4% | |
| Capex / Op. cash flow | 17.8% | 46.0% | 58.7% | 35.7% | 16.9% | |
| Capex / Depreciation | 79.7% | 240.5% | 244.5% | 145.5% | 114.0% | |
| Capex / Sales | 5.4% | 13.3% | 14.9% | 8.6% | 6.2% | |
| SG&A / Sales | 23.7% | 25.6% | 27.6% | 28.0% | 25.7% | |
| R&D / Sales | 13.0% | 13.7% | 14.0% | 14.1% | 11.8% | |
| Stock comp / Sales | 7.8% | 8.1% | 8.4% | 8.2% | 7.9% | |
| Intangibles / Total assets | 1.8% | 2.0% | 2.5% | 3.1% | 3.1% | |
| Days sales outstanding | 59d | 59d | 65d | 63d | 57d | |
| Days payables outstanding | 27d | 26d | 29d | 26d | 25d | |
| Operating cycle | 255d | 259d | 251d | 224d | 179d | |
| Cash conversion cycle | 228d | 233d | 222d | 197d | 154d |
Change by theme
Grouped by what each metric measures. Each figure is the change over the period shown — ▲ up ▼ down versus then.
Change over 1 year
Valuation
Market cap ▲+9.0%EV / Sales ▼-10.0%EV / EBITDA ▼-14.7%EV / Op. cash flow ▼-10.303Earnings yield ▲+0.002Graham number ▲+12.322
Profitability
Return on equity ▲+0.019Return on assets ▲+0.015Return on invested capital ▲+0.017Return on capital employed ▲+0.021Operating ROA ▲+0.012Income quality ▲+0.020Tax burden ▼-0.006
Efficiency
Days sales outstanding ▼-0.247Days payables outstanding ▲+1.234Operating cycle ▼-3.734Cash conversion cycle ▼-4.968Capex / Sales ▼-0.079R&D / Sales ▼-0.007
Balance-sheet strength
Current ratio ▲+0.800Net debt / EBITDA ▼-0.169Working capital ▲+2407600000.000Invested capital ▲+2977900000.000Intangibles / Total assets ▼-0.001
Change over 5 years
Valuation
Market cap ▲+58.0%EV / Sales ▼-10.9%EV / EBITDA ▼-13.1%EV / Op. cash flow ▲+5.028Earnings yield ▲+0.001Graham number ▲+34.703
Profitability
Return on equity ▲+0.018Return on assets ▲+0.013Return on invested capital ▲+0.003Return on capital employed ▲+0.011Operating ROA ▲+0.002Income quality ▼-0.156Tax burden ▼-0.039
Efficiency
Days sales outstanding ▲+1.965Days payables outstanding ▲+1.951Operating cycle ▲+75.861Cash conversion cycle ▲+73.910Capex / Sales ▼-0.008R&D / Sales ▲+0.013
Balance-sheet strength
Current ratio ▼-0.209Net debt / EBITDA ▼-0.223Working capital ▲+3078200000.000Invested capital ▲+6511500000.000Intangibles / Total assets ▼-0.012
Employee count
Peer market caps
Congressional trades
Recent trades
| Date | Representative | Type | Amount |
|---|---|---|---|
| 2026-05-01 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2026-01-30 | Gilbert Cisneros | Purchase | $1,001 - $15,000 |
| 2026-01-29 | Ro Khanna | Sale | $15,001 - $50,000 |
| 2026-01-13 | Ro Khanna | Purchase | $15,001 - $50,000 |
| 2025-12-10 | Gilbert Cisneros | Purchase | $1,001 - $15,000 |
| 2025-11-18 | Gilbert Cisneros | Purchase | $1,001 - $15,000 |
| 2025-10-07 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2025-09-05 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2025-09-03 | Josh Gottheimer | Sale | $1,001 - $15,000 |
| 2025-07-16 | Lisa McClain | Sale (Full) | $1,001 - $15,000 |
| 2025-07-10 | Lisa McClain | Purchase | $1,001 - $15,000 |
| 2025-06-09 | Lisa McClain | Sale (Partial) | $1,001 - $15,000 |
| 2025-04-21 | Bruce Westerman | Sale | $1,001 - $15,000 |
| 2025-04-09 | Josh Gottheimer | Sale (Partial) | $1,001 - $15,000 |
| 2025-04-07 | Julie Johnson | Sale | $1,001 - $15,000 |
| 2025-04-07 | Jefferson Shreve | Sale | $15,001 - $50,000 |
| 2025-03-03 | Bruce Westerman | Purchase | $1,001 - $15,000 |
| 2025-01-30 | Gilbert Cisneros | Purchase | $1,001 - $15,000 |
| 2025-01-29 | Josh Gottheimer | Sale | $1,001 - $15,000 |
| 2025-01-21 | Josh Gottheimer | Sale | $1,001 - $15,000 |
| 2025-01-10 | Josh Gottheimer | Sale | $1,001 - $15,000 |
| 2024-12-23 | Josh Gottheimer | Sale (Partial) | $1,001 - $15,000 |
| 2024-12-11 | Lisa McClain | Purchase | $1,001 - $15,000 |
| 2024-07-22 | Josh Gottheimer | Purchase | $1,001 - $15,000 |
| 2024-07-17 | Greg Landsman | Sale (Full) | $15,001 - $50,000 |
| 2024-07-17 | Greg Landsman | Sale (Full) | $1,001 - $15,000 |
| 2024-06-25 | Josh Gottheimer | Purchase | $1,001 - $15,000 |
| 2024-06-20 | Greg Landsman | Purchase | $15,001 - $50,000 |
| 2024-05-07 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2024-03-20 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2024-03-01 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2024-01-29 | Josh Gottheimer | Purchase | $1,001 - $15,000 |
| 2024-01-10 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2024-01-10 | Ro Khanna | Purchase | $15,001 - $50,000 |
| 2023-11-03 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2023-11-03 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2023-10-31 | Ro Khanna | Sale | $15,001 - $50,000 |
| 2023-10-27 | Josh Gottheimer | Sale (Partial) | $1,001 - $15,000 |
| 2023-10-24 | Greg Stanton | Sale | $1,001 - $15,000 |
| 2023-10-12 | Greg Landsman | Sale (Full) | $1,001 - $15,000 |
| 2023-10-10 | Ro Khanna | Purchase | $15,001 - $50,000 |
| 2023-10-02 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2023-09-26 | Greg Stanton | Purchase | $1,001 - $15,000 |
| 2023-09-01 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2023-08-29 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2023-08-02 | Greg Landsman | Sale (Partial) | $1,001 - $15,000 |
| 2023-07-28 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2023-07-20 | William R. Keating | Purchase | $1,001 - $15,000 |
| 2023-07-07 | Ro Khanna | Purchase | $15,001 - $50,000 |
| 2023-06-29 | Ro Khanna | Sale | $100,001 - $250,000 |
| 2023-06-26 | Ro Khanna | Sale | $15,001 - $50,000 |
| 2023-05-30 | Greg Landsman | Purchase | $1,001 - $15,000 |
| 2023-05-30 | Josh Gottheimer | Sale | $1,001 - $15,000 |
| 2023-05-04 | Greg Landsman | Purchase | $1,001 - $15,000 |
| 2023-05-01 | Josh Gottheimer | Purchase | $1,001 - $15,000 |
| 2023-03-06 | Daniel Goldman | Purchase | $15,001 - $50,000 |
| 2023-02-01 | Greg Landsman | Purchase | $1,001 - $15,000 |
| 2023-01-31 | Daniel Goldman | Purchase | $1,001 - $15,000 |
| 2022-12-05 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2022-10-21 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2022-10-20 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2022-10-12 | Kathy Manning | Sale (Full) | $1,001 - $15,000 |
| 2022-09-29 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2022-09-12 | Kathy Manning | Purchase | $1,001 - $15,000 |
| 2022-08-15 | Ro Khanna | Sale | $15,001 - $50,000 |
| 2022-07-25 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2022-06-28 | John Curtis | Sale (Full) | $1,001 - $15,000 |
| 2022-06-21 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2022-06-17 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2022-06-16 | Ro Khanna | Purchase | $50,001 - $100,000 |
| 2022-06-10 | Kathy Manning | Sale (Partial) | $1,001 - $15,000 |
| 2022-05-10 | Ro Khanna | Sale | $15,001 - $50,000 |
| 2022-05-05 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2022-05-05 | Ro Khanna | Sale | $15,001 - $50,000 |
| 2022-05-05 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2022-04-20 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2022-04-11 | Ro Khanna | Sale | $15,001 - $50,000 |
| 2022-02-28 | Donald Sternoff Beyer | Sale (Full) | $15,001 - $50,000 |
| 2022-02-23 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2022-02-23 | Kathy Manning | Purchase | $1,001 - $15,000 |
| 2022-02-17 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2022-02-17 | Ro Khanna | Purchase | $50,001 - $100,000 |
| 2022-02-14 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2022-01-26 | Josh Gottheimer | Sale (Partial) | $1,001 - $15,000 |
| 2022-01-21 | Ro Khanna | Sale | $15,001 - $50,000 |
| 2022-01-11 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2021-12-01 | Kathy Manning | Sale (Partial) | $1,001 - $15,000 |
| 2021-06-22 | John Curtis | Purchase | $1,001 - $15,000 |
| 2021-05-04 | Kathy Manning | Sale (Partial) | $1,001 - $15,000 |
| 2021-02-23 | Josh Gottheimer | Sale (Partial) | $1,001 - $15,000 |
| 2021-02-16 | Peter Meijer | Sale (Full) | $1,001 - $15,000 |
| 2020-11-05 | Donald Sternoff Beyer | Purchase | $1,001 - $15,000 |
| 2020-07-14 | Donald Sternoff Beyer | Sale (Full) | $1,001 - $15,000 |
| 2020-05-07 | Donald Sternoff Beyer | Sale (Full) | $1,001 - $15,000 |
| 2020-05-01 | Donald Sternoff Beyer | Sale (Full) | $1,001 - $15,000 |
| 2020-04-27 | Donald Sternoff Beyer | Sale (Full) | $1,001 - $15,000 |
| 2020-04-17 | Josh Gottheimer | Sale (Partial) | $1,001 - $15,000 |
| 2020-04-02 | Dean Phillips | Sale (Partial) | $1,001 - $15,000 |
| 2020-03-27 | John Curtis | Purchase | $1,001 - $15,000 |
| 2020-01-28 | Donald Sternoff Beyer | Purchase | $1,001 - $15,000 |
Recent news
- 2026-08-14 Breakfast News: Week in Review Nvidia turns financier, CAVA''s traffic sizzles, Berkshire ends its 3-year drought, and more
- 2026-08-13 Breakfast News: BBB Foods Opens Shops at Full Tilt TBBB rallies on strong expansion, Anthropic could IPO with $2 trillion valuation, and more
- 2026-08-12 ISRG''s US Procedure Growth Slows: Is ACA Headwind a Temporary Concern? ISRG''s US procedure growth slows in Q2, but ACA-related care deferrals may prove temporary as underlying demand and da Vinci 5 adoption remain strong.
- 2026-08-12 Intuitive Surgical: Priced For Precision Intuitive Surgical is rated a Hold, with a modeled +9.17% upside and a price target of $426.65. ISRG''s growth thesis centers on untapped ASC procedure volume, overstated remanufacturing risks, and remanufacturing''s role in expanding the installed base. Remanufacturing currently poses a limited threat, with sub-3% penetration and approval for only 4 out of 45+ instruments.
- 2026-08-12 This Intuitive Surgical Analyst Turns Bullish; Here Are Top 4 Upgrades For Wednesday Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- 2026-08-12 Intuitive Surgical (ISRG) Stock Has Plunged 33% in 2026. Here''s Why One Fund Manager Remains Bullish -- and Why I Do, Too. The stock may be down sharply, but don''t count it out -- and the lower price makes it more attractive.
- 2026-08-12 Here Are Wednesday’s Top Wall Street Analyst Research Calls: The Gap, Genmab, Hilton Worldwide, Intuitive Surgical, Marriott International, Merck, Novo Nordisk, Okta, and More With all eyes locked on this morning''s CPI release and the Strait of Hormuz nearly shut down, Wall Street analysts are already repositioning across hospitality, pharma, and tech before the market even opens.
- 2026-08-12 Oppenheimer Sees $500 for Intuitive Surgical as Rivals Stall Intuitive Surgical (ISRG) rose 0.90% premarket after Oppenheimer upgraded the robotic surgery company to Outperform from Perform with a $500 price target. The f
- 2026-08-11 The Number One Reason I Keep Buying Intuitive Surgical Now For The Long Run I keep hitting the buy button on Intuitive Surgical (NASDAQ:ISRG | ISRG Price Prediction), and the recent drawdown has only made me press it harder.
- 2026-08-10 ISRG Trades at a Premium P/E: Buy, Sell or Hold the Stock Now? ISRG''s premium valuation faces scrutiny as strong Q2 growth, higher margins and expanding robotic platforms support its 2026 outlook.